English  |  正體中文  |  简体中文  |  總筆數 :2853535  
造訪人次 :  45242070    線上人數 :  920
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

跳至: [ 中文 ] [ 數字0-9 ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
請輸入前幾個字:   

顯示項目 194071-194080 / 2346275 (共234628頁)
<< < 19403 19404 19405 19406 19407 19408 19409 19410 19411 19412 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
中國醫藥大學 2010-11 Antitumor Agents 286. Design, Synthesis and Structure-Activity Relationship of 3’R,4’R-Disubstituted-2’,2’-Dimethyldihydropyrano[2,3-f] Chromone (DSP) Analogs as Potent Chemosensitizers to Overcome Multidrug Resistance (Ting Zhou); (Qian Shi); (Kenneth F. Bastow)*; 李國雄(Kuo-Hsiung Lee)
中國醫藥大學 2011-03 Antitumor Agents 287. Substituted 4-amino-2H-pyran-2-one (APO) analogs reveal a new scaffold from neo-tanshinlactone with in vitro anticancer activity, (Yizhou Dong); (Kyoko Nakagawa-Goto); (Chin-Yu Lai); (Susan L. Morris-Natschke); (Kenneth F. Bastow); 李國雄(Kuo-Hsiung Lee)*
中國醫藥大學 2011-06 Antitumor Agents 288. Design, Synthesis, SAR and Biological Studies of Novel Heteroatom-Incorporated Antofine and Cryptopleurine Analogs as Potent and Selective Antitumor Agents (Xiaoming Yang);(Qian Shi);(Shuenn-Chen Yang);(Chi-Yuan Chen);(Sung-Liang Yu);(Kenneth F. Bastow);(Susan L. Morris-Natschke);(Pei-Chi Wu);(Chin-Yu Lai);吳天賞(Tian-Shung Wu);(Shiow-Lin Pan);(Che-Ming Teng);(Jau-Chen Lin);(Pan-Chyr Yang)*;李國雄(Kuo-Hsiung Lee)*
國立臺灣大學 2011 Antitumor Agents 288: Design, Synthesis, Sar, and Biological Studies of Novel Heteroatom-Incorporated Antofine and Cryptopleurine Analogues as Potent and Selective Antitumor Agents 俞松良; 李國雄; 吳天賞; 潘秀玲; 鄧哲明; 楊泮池; YU, SUNG-LIANG; LEE, KUO-HSIUNG; WU, TIAN-SHUNG; PAN, SHIOW-LIN; TENG, CHE-MING; YANG, PAN-CHYR
臺大學術典藏 2020-06-17T03:01:50Z Antitumor agents 288: Design, synthesis, SAR, and biological studies of novel heteroatom-incorporated antofine and cryptopleurine analogues as potent and selective antitumor agents Yang X. ;Shi Q. ;Yang S.-C. ;Chen C.-Y. ;Sung-Liang Yu ;Bastow K.F. ;Morris-Natschke S.L. ;Wu P.-C. ;Lai C.-Y. ;Wu T.-S. ;Pan S.-L. ;Teng C.-M. ;Lin J.-C. ;Yang P.-C. ;Lee K.-H.; Yang X.; Shi Q.; Yang S.-C.; Chen C.-Y.; SUNG-LIANG YU; Bastow K.F.; Morris-Natschke S.L.; Wu P.-C.; Lai C.-Y.; Wu T.-S.; Pan S.-L.; Teng C.-M.; Lin J.-C.; Yang P.-C.; Lee K.-H.
臺大學術典藏 2020-12-02T02:34:08Z Antitumor agents 288: Design, synthesis, SAR, and biological studies of novel heteroatom-incorporated antofine and cryptopleurine analogues as potent and selective antitumor agents PAN-CHYR YANG et al.; Yang X.; Yang X. ;Pan-Chyr Yang Et Al.
中國醫藥大學 2011-12 Antitumor Agents 291 Expanded B-Ring Modification Study of 6,8,8-Triethyl Desmosdumotin B Analogues as Multidrug-Resistance Selective Agents (Kyoko Nakagawa-Goto)*;(Kenneth F Bastow);(Emika Ohkoshi);(Susan L Morris-Natschke);李國雄(Kuo-Hsiung Lee)*
中國醫藥大學 2012-03 Antitumor Agents 292. Design, Synthesis and Pharmacological Study of S- and O-Substituted 7-Mercapto-or Hydroxy-Coumarins and Chromones as Potent Cytotoxic Agents (Ying Chen);(Hong-Rui Liu);(Hong-Shan Liu);(Ming Cheng);(Peng Xia)*;(Keduo Qian);(Pei-Chi Wu);(Chin-Yu Lai);(Yi Xia);(Zheng-Yu Yang);(Susan L. Morris-Natschke);李國雄(Kuo-Hsiung Lee)*
國立臺灣大學 2012 Antitumor Agents 295. E-Ring Hydroxylated Antofine and Cryptopleurine Analogues as Antiproliferative Agents: Design, Synthesis, and Mechanistic Studies Yang, Xiaoming; Shi, Qian; Lai, Chin-Yu; Chen, Chi-Yuan; Ohkoshi, Emika; Yang, Shuenn-Chen; Wang, Chih-Ya; Bastow, Kenneth F.; Wu, Tian-Shung; Pan, Shiow-Lin; Teng, Che-Ming; Yang, Pan-Chyr; Lee, Kuo-Hsiung; 楊泮池
臺大學術典藏 2020-12-02T02:33:57Z Antitumor agents 295. E-ring hydroxylated antofine and cryptopleurine analogues as antiproliferative agents: Design, synthesis, and mechanistic studies Yang X.; Shi Q.; Lai C.-Y.; Chen C.-Y.; Ohkoshi E.; Yang S.-C.; Wang C.-Y.; Bastow K.F.; Wu T.-S.; Pan S.-L.; Teng C.-M.; Pan-Chyr Yang; Lee K.-H.; Yang X.; PAN-CHYR YANG et al.

顯示項目 194071-194080 / 2346275 (共234628頁)
<< < 19403 19404 19405 19406 19407 19408 19409 19410 19411 19412 > >>
每頁顯示[10|25|50]項目